Nanosonics Is An Australian Public Company Specializing In Infection Prevention Technologiesparticularly Automated Disinfection Solutionsestablished As A Leader In The Medical And Surgical Equipment Manufacturing Industrynanosonics Employs 466 Staff Globally And Reported A Revenue Of $176 7 Million In 2024Showing Significant Growth From Previous Years The Company Develops Automated Disinfection Systems Aimed At Preventing Healthcare Associated Infectionsfocusing On The Decontamination Of Critical Medical Equipmentespecially Ultrasound Instrumentsnanosonics Is Committed To Research Driven Innovationcontinually Investing In R&D To Enhance Its Infection Control Offeringstheir Solutions Are Designed For Healthcare Providers That Require High Level Disinfection Protocolsemphasizing The Importance Of Infection Prevention In Clinical Settingsnanosonics Operates Under A Professional Governance Frameworkled By Ceo Michael Kavanagh And Chairman Maurie Stangthe Company S Commitment To Transparency And Stakeholder Accountability Is Reflected In Its Public Listing And Financial Reporting
No conferences found for this company.
| Company Name | Nanosonics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
